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Abstract
The qualified presumption of safety (QPS) approach was developed to provide a regularly updated
generic pre-evaluation of the safety of biological agents, intended for addition to food or feed, to support
the work of EFSA’s Scientific Panels. The QPS approach is based on an assessment of published data for
each agent, with respect to its taxonomic identity, the body of relevant knowledge, safety concerns and
occurrence of antimicrobial resistance. Safety concerns identified for a taxonomic unit (TU) are, where
possible, confirmed at the species/strain or product level and reflected by ‘qualifications’. In the period
covered by this statement, no new information was found that would change the status of previously
recommended QPS TUs. Schizochytrium limacinum, which is a synonym for Aurantiochytrium limacinum,
was added to the QPS list. Of the 78 microorganisms notified to EFSA between October 2020 and March
2021, 71 were excluded; 16 filamentous fungi, 1 Dyella spp., 1 Enterococcus faecium, 7 Escherichia coli,
1 Streptomyces spp., 1 Schizochytrium spp. and 44 TUs that had been previously evaluated. Seven TUs
were evaluated: Corynebacterium stationis and Kodamaea ohmeri were re-assessed because an update
was requested for the current mandate. Anoxybacillus caldiproteolyticus, Bacillus paralicheniformis,
Enterobacter hormaechei, Eremothecium ashbyi and Lactococcus garvieae were assessed for the first
time. The following TUs were not recommended for QPS status: A. caldiproteolyticus due to the lack of a
body of knowledge in relation to its use in the food or feed chain, E. hormaechei, L. garvieae and
K. ohmeri due to their pathogenic potential, E. ashbyi and C. stationis due to a lack of body of knowledge
on their occurrence in the food and feed chain and to their pathogenic potential. B. paralicheniformis was
recommended for the QPS status with the qualification ‘absence of toxigenic activity’ and ‘absence of
genetic information to synthesize bacitracin’.
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Summary
The European Food Safety Authority (EFSA) asked the Panel on Biological Hazards (BIOHAZ) to
deliver a Scientific Opinion on the maintenance of the qualified presumption of safety (QPS) list. The
QPS list contains biological agents, intentionally added to food and feed, which have achieved QPS
status. The request included three specific tasks as mentioned in the Terms of Reference (ToR).
The QPS process was developed to provide a harmonised generic pre-evaluation procedure to
support safety risk assessments of biological agents performed by EFSA’s scientific Panels and Units.
This process assesses the taxonomic identity, body of relevant knowledge and safety of biological
agents. Safety concerns identified for a taxonomic unit (TU) are, where possible, confirmed at strain or
product level, reflected as ‘qualifications’ that should be assessed at the strain level by EFSA’s Scientific
Panels. A generic qualification for all QPS bacterial TUs applies in relation to the absence of acquired
genes conferring resistance to clinically relevant antimicrobials (EFSA, 2008).
The list of microorganisms is maintained and re-evaluated approximately every 6 months in a
Panel Statement. The Panel Statement also includes the evaluation of microbiological agents newly
notified to EFSA within the previous 6-month period.
The first ToR requires ongoing updates of the list of biological agents notified to EFSA, in the
context of a technical dossier for safety assessment. The overall list (https://doi.org/10.5281/zenodo.
4917414) was updated with the notifications received between October 2020 and March 2021. Within
this period, 78 notifications were received by EFSA, of which 55 were proposed for evaluation in feed,
13 for use as food enzymes, food additives and flavourings, 8 as novel foods and 2 as plant protection
products. The new notifications received between October 2020 and March 2021 are included in the
current Statement (see Appendix F).
The second ToR concerns the revision of the TUs previously recommended for the QPS list and their
qualifications. For this revision, articles published from July until December 2020 were assessed. The
articles were retrieved and assessed through an extensive literature search (ELS) protocol available in
Appendix B (see https://doi.org/10.5281/zenodo.5016562) and the search strategies in Appendix C
(see https://doi.org/10.5281/zenodo.5016711). No new information was found that would affect the
QPS status of those TUs or their qualifications. Schizochytrium limacinum, which is a synonym for
Auranthiochytrium limacinum, is added to the QPS list.
The third ToR requires a (re)assessment of new TUs notified to EFSA, for their suitability for
inclusion in the updated QPS list at the Knowledge Junction in Zenodo (https://doi.org/10.5281/zenod
o.4917383, Appendix E).
Seven of the 78 notifications received, corresponding to 7 TUs, were evaluated for possible QPS
status; Corynebacterium stationis and Kodamaea ohmeri were re-assessed because an update was
requested in relation to the current mandate. Five TUs (Anoxybacillus caldiproteolyticus, Bacillus
paralicheniformis, Enterobacter hormaechei, Eremothecium ashbyi and Lactococcus garvieae) were
assessed for the first time. The following conclusions were drawn:
• Anoxybacillus caldiproteolyticus is not recommended for QPS status due to a lack of a body of
knowledge on its occurrence in the food and feed chain.
• B. paralicheniformis is recommended for the QPS status with the qualification ‘absence of
toxigenic activity’ and ‘absence of genetic information to synthesize bacitracin’.
• Corynebacterium stationis is not recommended for QPS status due to a lack of a body of
knowledge in relation to its occurrence in the food and feed chain and to possible safety
concerns in relation to human health.
• Enterobacter hormaechei is not recommended for QPS status due to its pathogenic potential
for humans and animals.
• Eremothecium ashbyi is not recommended for QPS status due to a lack of a body of
knowledge on its occurrence in the food and feed chain and its pathogenicity for plants.
• Kodamaea ohmeri is not recommended for QPS status due to safety concerns in relation to
human health.
• Lactococcus garvieae is not recommended for QPS status due to its pathogenic potential for
humans and animals.
The remaining 71 notifications were excluded from QPS evaluation for the following reasons: 25
notifications were related to microorganisms that are generally excluded from QPS evaluation (16 were
notifications of filamentous fungi, 1 of Enterococcus faecium, 7 of Escherichia coli, 1 Streptomyces
spp.), 2 notifications (Dyella spp. and Schizochytrium sp. strain CABIO-A-2) were only a genus, or a
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strain in the case of Schizochytrium, and not a species and therefore not suitable for the QPS
approach and 44 (including the newly classified Lactiplantibacillus plantarum, previously known as
Lactobacillus plantarum) were related to TUs that already have QPS status and did not require further
evaluation.
BIOHAZ statement on QPS: suitability of taxonomic units notified until March 2021
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1. Introduction
The qualified presumption of safety (QPS) approach was developed by the EFSA Scientific
Committee to provide a generic concept for risk assessment within the European Food Safety Authority
(EFSA) for microorganisms intentionally introduced into the food chain, in support of the respective
Scientific Panels and Units in the context of market authorisations for their use in food and feed,
requiring an EFSA safety assessment (EFSA, 2007). The list, first established in 2007, has been
continuously revised and updated. A Panel Statement is published approximately every 6 months.
These Panel Statements include the results of the assessment of relevant new papers related to the
TUs with QPS status. They also contain the assessment of newly arrived TUs to the EFSA Units on
Feed, Food Ingredients and Packaging (FIP), Nutrition, Pesticides and Genetically Modified Organisms
(GMO). After 3 years, a QPS opinion is published summarising the results of the Panel Statements
published in that period.
1.1. Background and Terms of Reference as provided by EFSA
A wide variety of microorganisms are intentionally added at different stages of the food and feed
chain. In the context of applications for market authorisation of these biological agents used, either
directly or as sources of food and feed additives, food enzymes and plant protection products, EFSA is
requested to assess their safety.
EFSA’s work on QPS activities began in 2004 when the Scientific Committee issued a scientific
opinion in continuation of the 2003 working document ‘On a generic approach to the safety
assessment of microorganisms used in feed/food and feed/food production’ prepared by a working
group consisting of members of the former Scientific Committee on Animal Nutrition, the Scientific
Committee on Food and the Scientific Committee on Plants of the European Commission.1 The
document, made available for public consultation, proposed the introduction of the concept of
Qualified Presumption of Safety (QPS), to be applied to selected groups of microorganisms.
Microorganisms not considered suitable for QPS status would remain subject to a full safety
assessment. EFSA management asked its Scientific Committee to consider whether the QPS approach
could be applied to the safety assessment of microorganisms across the various EFSA Scientific Panels.
In doing so, the Committee was required to take into account the response of the stakeholders to the
QPS approach. In its 2005 opinion (EFSA Scientific Committee, 2005), the Scientific Committee
concluded that the QPS approach could provide a generic assessment system that could be applied to
all requests received by EFSA for the safety assessments of microorganisms deliberately introduced
into the food and feed chain. Its introduction was intended to improve transparency and ensure
consistency in the approach used across the EFSA Panels. Applications involving a taxonomic unit
belonging to a species that falls within a QPS group do not require a full safety assessment.
Several taxonomic units (usually species for bacteria and yeasts; families for viruses) have been
included in the QPS list, either following notifications to EFSA, or proposals made initially by
stakeholders during a public consultation in 2005, even if they were not yet notified to EFSA (EFSA
Scientific Committee, 2005). The EFSA Scientific Committee reviewed the range and numbers of
microorganisms likely to be the subject of an EFSA Opinion and, in 2007, published a list of
microorganisms recommended for the QPS list.
In their 2007 opinion (EFSA, 2007), the Scientific Committee recommended that a QPS approach
should provide a generic concept to prioritise and to harmonise safety risk assessment of
microorganisms intentionally introduced into the food chain, in support of the respective Scientific
Panels and EFSA Units in the frame of the market authorisations for their use in the food and feed
chain. The same Committee recognised that there would have to be continuing provision for reviewing
and modifying the QPS list and in line with this recommendation, the EFSA Panel on Biological Hazards
(BIOHAZ) took the prime responsibility for this and started reviewing annually the existing QPS list. In
2008, the first annual QPS update was published (EFSA, 2008).
In 2014, the BIOHAZ Panel, in consultation with the Scientific Committee, decided to change the
revision procedure; the overall assessment of the taxonomic units previously recommended for the
QPS list (EFSA BIOHAZ Panel, 2013) was no longer carried out annually but over a 3-year period. From
2017, the search and revision of the possible safety concerns linked to those taxonomic units started
instead to be carried out every 6 months through extensive literature searches (ELS). The update of
the 2013 QPS list (EFSA BIOHAZ Panel, 2013) was done in 2016 (EFSA BIOHAZ Panel, 2017). From
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2016 on, the QPS list (https://doi.org/10.5281/zenodo.1146566) and the list of notifications to EFSA
(https://doi.org/10.5281/zenodo.3607183) are constantly updated, independent of the QPS opinion and
available at the Knowledge Junction in Zenodo. The most recent QPS opinion (EFSA BIOHAZ Panel,
2020a) summarises the main results of the 3-year ELS on the QPS TUs, together with an update of the
process for granting QPS status. In the meantime, every 6 months a Panel Statement, compiling the
assessments for a QPS status of the microbiological agents notified to EFSA requested by the Feed Unit,
the Food Ingredients and Packaging (FIP) Unit, the Nutrition Unit, the Pesticides Unit and the Genetically
Modified Organisms (GMO) Unit, as well as the summary of each 6-month ELS exercise, has been
produced and published. Each QPS Panel Statement contains the evaluations of the new notifications for
microorganisms submitted for possible QPS status. It also contains the result of a standardized extensive
literature search performed every 6 months regarding possible new safety concerns related to the TUs
already included in the QPS list. The data identified are used to decide whether any TU may or may not
remain on the QPS list, and whether any qualifications need to be revised.
Establishing a QPS status is based on four pillars: [1] the taxonomic grouping (TU) for which QPS is
sought (‘taxonomic identification’); [2] whether sufficient relevant information is available about the
proposed group of organisms to conclude on human/animal exposure by food/ feed (‘body of
knowledge’); [3] whether the grouping proposed contains known pathogens (‘safety’) and, finally, [4]
the intended end use (‘intended use’). If a hazard related to a TU is identified, which can be tested at
the strain or product level, a ‘qualification’ to exclude that hazard may be established and added. The
subject of these qualifications for the microbial strain under investigation is evaluated by the EFSA Unit
to which the application dossier has been allocated. Absence of acquired genes coding for resistance
to antimicrobials relevant for humans and animals is a generic qualification for all bacterial TUs; the
absence of antimycotic resistance should be proven if the pertinent yeasts are to be used as viable
organisms in the food or feed chains. The qualification ‘for production purpose only’ implies the
absence of viable cells of the production organism in the final product and can also be applied to food
and feed products based on microbial biomass (EFSA BIOHAZ Panel, 2020a).
Because the QPS evaluation is, after its initial creation, only triggered through an application dossier
notified to EFSA, the QPS list is not exhaustive.
In summary, the QPS evaluation provides a generic safety pre-assessment approach for use within
EFSA that covers safety concerns for humans, animals and the environment. In the QPS concept, a
safety assessment of a defined taxonomic unit is performed independently of the legal framework
under which the application is made in the course of an authorisation process. Although general
human safety is part of the evaluation, specific issues connected to type and level of exposure of users
handling the product (e.g. dermal contact, inhalation, ingestion) are not addressed. In the case of
Genetically Modified Microorganisms (GMM) for which the species of the recipient strain qualifies for
the QPS status, and for which the genetically modified state does not give rise to safety concerns, the
QPS approach can be extended to genetically modified production strains (EFSA BIOHAZ Panel, 2018).
The assessment of potential allergenic microbial residual components is beyond the QPS remit;
however, if there is science-based evidence for a microbial species it is reported. These aspects are
separately assessed, where applicable, by the EFSA Panel responsible for assessing the application.
The lowest TU for which the QPS status is granted is the species level for bacteria, yeasts and
protists/algae, and family for viruses.
Filamentous fungi, bacteriophages, Streptomycetes, Oomycetes, Enterococcus faecium, Escherichia
coli and recently also Clostridium butyricum (EFSA BIOHAZ Panel, 2020a,c) are excluded from the QPS
assessments based on an ambiguous taxonomic position or the possession of potentially harmful traits.
The Terms of Reference are as follows:
ToR 1: Keep updated the list of biological agents being notified in the context of a technical dossier
to EFSA Units such as Feed, Pesticides, Food Ingredients and Packaging (FIP) and Nutrition, for
intentional use directly or as sources of food and feed additives, food enzymes and plant protection
products for safety assessment.
ToR 2: Review taxonomic units previously recommended for the QPS list and their qualifications
when new information has become available. The latter is based on a review of the updated literature
aiming at verifying if any new safety concern has arisen that could require the removal of a taxonomic
unit from the list, and to verify if the qualifications still efficiently exclude safety concerns.
ToR 3: (Re) assess the suitability of new taxonomic units notified to EFSA for their inclusion in the
QPS list. These microbiological agents are notified to EFSA and requested by the Feed Unit, the FIP
Unit, the Nutrition Unit or by the Pesticides Unit.
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2. Data and methodologies
2.1. Data
In reply to ToR 3, (re)assessment of the suitability of TUs notified within the time period covered by
this Statement (from October 2020 to March 2021) was carried out. The literature review considered
the identification, the body of knowledge, the potential safety concerns related to human and animal
health and to organisms in the environment (EFSA BIOHAZ Panel, 2020a). The environmental risk
assessment of plant protection products is not included in the QPS assessment but carried out by the
Pesticide Peer Review (PPR) Unit based on the information in the application dossier. The knowledge
on relevant acquired antimicrobial resistance (AMR) is reflected in the safety sections of this document.
Relevant databases, such as PubMed, Web of Science, CAB Abstracts or Food Science Technology
Abstracts (FSTA) and Scopus, were searched. More details on the search strategy, search keys and
approach are described in Appendix A. Only the literature that is considered, based on expert
judgement, to be relevant for the QPS assessment is reflected in the Statement.
Only valid TUs covered by the relevant international committees on the nomenclature for
microorganisms are considered for the QPS assessment.
2.2. Methodologies
2.2.1. Evaluation of a QPS recommendation for taxonomic units notified to EFSA
In response to ToR 1, the EFSA Units were asked to update the list of biological agents being
notified to EFSA. A total of 78 notifications were received between October 2020 and March 2021, of
which 55 were for evaluation for use in feed, 13 for use as food enzymes, food additives and
flavourings, 8 as novel foods and 2 as plant protection products (Table 1).2
In response to ToR 3, seven of the 78 notifications, corresponding to seven TUs, were evaluated for
possible QPS status, five of these (Anoxybacillus caldiproteolyticus, Bacillus paralicheniformis,
Enterobacter hormaechei, Eremothecium ashbyi and Lactococcus garvieae) for the first time. The other
two, Corynebacterium stationis and Kodamaea ohmeri, were re-assessed because an update was
requested in the current mandate. The remaining 71 notifications were excluded from QPS evaluation for
the following reasons: 25 notifications were related to microorganisms that are generally excluded from
QPS evaluation (16 were notifications of filamentous fungi, 1 of Enterococcus faecium, 7 of Escherichia
coli, 1 Streptomyces spp.), two notifications were not suitable for the QPS approach, i.e. Dyella spp.
because it is a genus and Schizochytrium sp. strain CABIO-A-2 because it is a strain, not a species, and 44
(including newly classified Lactiplantibacillus plantarum, previously known as Lactobacillus plantarum)
were related to TUs that already had QPS status and did not require further evaluation in this mandate.
Table 1: Notifications received by EFSA, per risk assessment area and by biological group, from
October 2020 to March 2021
Risk assessment area
Not evaluated in this








Feed 39 13 3 55
Bacteria 35 5 2 42
Filamentous fungi 0 8 0 8
Yeasts 4 0 1 5
Novel foods 2 4 2 8
Bacteria 0 3 2 5
Filamentous fungi 0 0 0 0
Protists/Algae 1 1 0 2
BIOHAZ statement on QPS: suitability of taxonomic units notified until March 2021
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2.2.2. Monitoring of new safety concerns related to species with QPS status
In reply to ToR 2, concerning the revision of the TUs previously recommended for the QPS list and
their qualifications, an extensive literature search (ELS) was conducted as described in Appendix B –
ELS protocol, see https://doi.org/10.5281/zenodo.5016562, and in Appendix C Search strategies – see
https://doi.org/10.5281/zenodo.5016711, respectively.
The Artificial Intelligence (AI) function was used for pre-screening of papers for Bifidobacterium
spp., lactobacilli, Lactococcus lactis, Bacillus spp. and yeasts, followed by a second screening of those
articles carried out by two experts.
The aim of the ELS was to identify any publicly available scientific studies reporting on safety
concerns for humans, animals or the environment, caused by QPS organisms since the previous QPS
review (i.e. publications from July to December 2020).
For case reports of human infections or intoxications, important additional information includes
whether any negative impacts are confined to persons with conditions favouring opportunistic
infections, for example immunosuppression, and whether transmission occurred through food or other
routes, when described (e.g. medical devices). Studies indicating the presence of virulence factors
(e.g. toxins and enzymes that may contribute to the pathogenicity of the microorganism) in the TU are
also reported as relevant when identifying potential safety concerns.
Several of the QPS-TUs are sporadically reported as causing infections in individuals with recognised
predisposing conditions for the acquisition of opportunistic infections, e.g. cardiovascular conditions
associated with endocarditis, people in the lower or upper age spectrum, or with other conditions
which can lead to impairment of the immunological system, such as patients subjected to transplants,
undergoing cancer therapy, suffering from physical trauma or tissue damage or HIV patients.
Moreover, gastrointestinal tract-related conditions with mucosal impairment can also be a predisposing
factor for infection. Previous use of the microorganisms being assessed as food supplements for
humans was reported in many of these cases. A living microorganism used as a food supplement does
not fall under the remit of the QPS assessment because regulation does not require an EFSA
assessment. Nevertheless, the QPS assessment takes into consideration these reports, extracting
relevant information whenever justified. For a detailed protocol of the process and search strategies,
refer to Appendices B and C.
Risk assessment area
Not evaluated in this








Yeasts 1 0 0 1
Plant protection products 0 2 0 2
Bacteria 0 0 0 0
Filamentous fungi 0 2 0 2
Viruses 0 0 0 0
Food enzymes, food additives and
flavourings
3 8 2 13
Bacteria 3 2 1 6
Filamentous fungi 0 6 0 6
Yeasts 0 0 1 1
Genetically modified organism 0 0 0 0
Bacteria 0 0 0 0
Total 44 27 7 78
QPS: qualified presumption of safety.
(a): The number includes 16 notifications of filamentous fungi, 1 of Enterococcus faecium (bacterium), 7 of Escherichia coli
(bacterium) and 1 of Streptomyces spp. (bacterium), all excluded from QPS evaluation, as well as 1 of Dyella spp. and 1 of
Schizochytrium sp. strain CABIO-A-2 which are only a genus or strain and not a species and therefore not suitable for the
QPS approach.
(b): Seven notifications corresponding to seven TUs, two were last evaluated in 2020 (Corynebacterium stationis and Kodamaea
ohmeri) and five were evaluated for the first time (Anoxybacillus caldiproteolyticus, Bacillus paralicheniformis, Enterobacter
hormaechei, Eremothecium ashbyi and Lactococcus garvieae).
BIOHAZ statement on QPS: suitability of taxonomic units notified until March 2021
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After removal of duplicates, 2,770 records were submitted to the title screening step, which led to
the exclusion of 2,581 of these. The remaining 189 records were found eligible for the title and
abstract screening step, which led to the exclusion of 113 of these. Of the 76 articles that finally
reached the article evaluation step (full text), 39 were considered to report a potential safety concern
and were further analysed.
The flow of records from their identification by the different search strategies (as reported in
Appendix C) to their consideration as potentially relevant papers for QPS is shown in Table 2.
3. Assessment
The search strategy (key words, literature databases, number of papers found) followed for the
assessment of the suitability of TUs notified to EFSA for their inclusion in the updated QPS list (reply to
ToR 3) can be found in Appendix A.














Number of articles retrieved
Bacteria (total) 1,939 72 32 14
Bacillus spp.(a) 557 13 4 2
Bifidobacterium
spp.(a)
150 14 8 2
Carnobacterium
divergens
8 0 0 0
Corynebacterium
glutamicum





200 2 2 0
Lactobacilli(a) 423 14 7 5
Lactococcus lactis(a) 126 11 2 0
Leuconostoc spp. 95 10 6 5
Microbacterium
imperiale
1 0 0 0
Oenococcus oeni 36 2 1 0
Pasteuria nishizawae 1 0 0 0
Pediococcus spp. 193 4 2 0
Propionibacterium
spp.
36 0 0 0
Streptococcus
thermophilus
79 1 0 0
Viruses (total) 74 1 0 0
Alphaflexiviridae/
Potyviridae
31 0 0 0
Baculoviridae 43 1 0 0
Yeasts(a) 673 74 36 21
Protists/Algae 84 42 8 4
Total 2,770 189 76 39
Excluded 2,581 113 37
(a): The numbers of references pre-screened by AI and excluded are not reported in the table and are for: Bifidobacterium spp.
(165), lactobacilli (430), Lactococcus lactis (149), Bacillus spp. (566), yeasts (676).
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3.1. Taxonomic units evaluated during the previous QPS mandate and
re-evaluated in the current Statement
3.1.1. Bacteria
Corynebacterium stationis
C. stationis was recently evaluated (EFSA BIOHAZ Panel, 2020b) and was not recommended as
QPS due to a lack of body of relevant knowledge.
Identity
C. stationis (synonym Achromobacter stationis) is a valid species with standing in nomenclature. It
was described by Bernard et al. (2010), grouping Brevibacterium stationis ATCC 14403 and C.
ammoniagenes ATCC 6872. Those strains can be discriminated from other Corynebacterium species by
16S rRNA gene and rpoB sequencing.
Body of knowledge
The body of knowledge for C. stationis is limited. The type strain was isolated from seawater
(Bernard et al., 2010). Other strains of this species were isolated from a human infant stool sample
(Bernard et al., 2010) and found in a population community from a compost produced by different
types of wastewater sludge (Tashiro et al., 2016). C. stationis is used in experimental trials as an
indicator for improving UV seawater disinfection treatment (Rubio et al., 2013). A strain of C. stationis
was used to produce disodium 50-inosinate for use as a feed additive (EFSA FEEDAP Panel, 2020).
Safety concerns
Two clinical C. stationis isolates were obtained from blood cultures from a 62-year-old male with a
chest infection, and a 66-year-old female; no further clinical information was provided (Bernard et al.,
2010). In a recent article, C. stationis was identified among bacteria causing diabetic foot infection and
presenting resistance to antibiotics (Henciya et al., 2020). C. stationis has been isolated from the raw
milk of cows with mastitis (Leon-Galvan et al., 2015; Anaya-Lopez et al., 2006; Mahmmod et al., 2018)
and on teat skin (Mahmmod et al., 2018); no invasion was observed in bovine mammary epithelial
cells (Anaya-Lopez et al., 2006).
Conclusion on a recommendation for QPS status
C. stationis cannot be recommended for QPS status due to a lack of body of knowledge on its




Kodamaea ohmeri was recently evaluated (EFSA BIOHAZ Panel, 2020b) and not recommended for
QPS due to safety concerns.
Identity
K. ohmeri is a yeast within the Saccharomycetales order. A synonym of K. ohmeri is Pichia
ohmeri and the teleomorphic form is Candida guilliermondii var. membranaefaciens (Kurtzman et al.,
2011). It is a biologically under-investigated taxon and its relationship with other taxa within the Order
Saccharomycetales is uncertain (Lumbsch and Huhndorf, 2007). Currently, it classified in the Class
Ascomyceta and the Saccharomycetaceae family. Correct identification apparently remains a challenge.
Body of knowledge
K. ohmeri has been recovered from a broad variety of sources. From a biotechnological point of
view, this species is used in the production of xylitol from glucose and the conversion of xylulose to
xylitol (Kurtzman et al., 2011).
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Safety concerns
Up to 2020, more than 70 cases of invasive fungaemia due to the yeast K. ohmeri have been
reported (Kanno et al., 2017; Ioannou and Papakitsou, 2020). A patient with a severe fungaemic
pulmonary infection was diagnosed with K. ohmeri (Kanno et al., 2017).
Conclusions on a recommendation for QPS status
The above information confirms our previous Statement (EFSA BIOHAZ Panel, 2020b), that K.
ohmeri cannot be recommended for QPS status due to safety concerns in relation to human health.




A. caldiproteolyticus is an aerobic, Gram-positive, sporulating, thermophilic bacterial species with
standing in nomenclature (Coorevits et al., 2012). The type strain was isolated from sewage and
initially classified as Geobacillus caldoproteolyticus (Chen et al., 2004).
Body of knowledge
A. caldiproteolyticus was first isolated and used for the production of a thermostable protease
(Chen et al., 2004), a phenotypic trait later confirmed by another strain that generated a keratinase
(Reis et al., 2020). Strains of the species have also been isolated from hot springs (Najar et al., 2018).
A. caldiproteolyticus has been implicated in the generation of biofilms on dairy abiotic surfaces (Karaca
et al., 2019).
Safety concerns
No safety concerns were reported for A. caldiproteolyticus.
Conclusions on a recommendation for the QPS status
A. caldiproteolyticus cannot be recommended for the QPS status due to lack of body of knowledge
on its occurrence in the food and feed chain.
Bacillus paralicheniformis
Identity
B. paralicheniformis is a valid species name with standing in nomenclature (Oren and Garrity,
2016). B. paralicheniformis are Gram-positive, facultatively anaerobic, mobile, endospore-forming rods;
producing catalase but not oxidase. Based on phylogenomic analysis of all available genomes of the B.
licheniformis group, a number of strains, originally designated as B. licheniformis, were reclassified as a
new species; B. paralicheniformis (Dunlap et al., 2015). The type strain was isolated from
cheonggukjang, a Korean fermented soybean food product.
Body of Knowledge
B. paralicheniformis has been isolated from the food product cheonggukjang (Dunlap et al., 2015),
from kimchi, a traditionally, spontaneously fermented vegetable Korean food product (Khan et al.,
2018) and from whey powder as a contaminant (McHugh et al., 2018). B. paralicheniformis were
reported as plant-associated bacteria, displaying growth promoting abilities (Annapurna et al., 2018)
and the potential to be used as phytopathogen biocontrol agents (Wang et al., 2017; Pylro et al.,
2019; Jinal et al., 2020; Ramirez-Carino et al., 2020). B. paralicheniformis strains also have the
potential to be used for biotechnological purposes and for bioremediation (Rahman et al., 2019; Khan
et al., 2018; SanthaKalaikumari et al., 2021; Ganesh Kumar et al., 2021).
Ahire et al. (2020) reported the production of a bacitracin, an antimicrobial peptide active against a
range of Gram-positive bacteria, by strains of B. paralicheniformis. The ability to produce bacitracin is
reported for a subset of B. paralicheniformis (Du et al., 2019).
BIOHAZ statement on QPS: suitability of taxonomic units notified until March 2021
www.efsa.europa.eu/efsajournal 12 EFSA Journal 2021;19(7):6689
Safety concerns
No negative effects in relation to B. paralicheniformis were reported. All strains classified as B.
paralicheniformis are reported to have phenotypic resistance to erythromycin as well as chromosomal
erythromycin resistance genes (Lee and Jeong, 2017; Agersø et al., 2018, 2019; Jeong et al., 2020).
Conclusions on a recommendation for the QPS status
B. paralicheniformis is recommended for the QPS status with the qualification ‘absence of toxigenic
activity’ and ‘absence of genetic information to synthesize bacitracin’.
Enterobacter hormaechei
Identity
E. hormaechei is a TU with standing in nomenclature. It was first described by O’Hara et al. (1989)
amended by Hoffmann et al. (2005) and updated by Oren and Garrity (2017). It is currently placed
within the E. cloacae complex, together with five other species and six additional genovars (Hoffmann
et al., 2005; Sutton et al., 2018), but further taxonomic restructuration might occur based on the
description of new species and subspecies by Wu et al. (2020).
Body of Knowledge
E. hormaechei has been isolated as a contaminant from food (Indugu et al., 2020; Sadek et al.,
2020), as an endophyte from plants (Khalaf and Raizada, 2020; Tshishonga and Serepa-Dlamini, 2019)
and from the gastrointestinal tracts of insects (Asimakis et al., 2019). Isolates of E. hormaechei are
able to degrade lutein, a plant carotenoid (Zhong et al., 2017). Enhancing soil fertility and P- and K-
uptake by plants have been reported for E. hormaechei (Roslan et al., 2020).
Safety concerns
E. hormaechei is an opportunistic human pathogen, causing mainly nosocomial infections
(Townsend et al., 2008; Roberts et al., 2020). It has frequently been reported as the cause of human
disease in susceptible individuals, in association with multidrug resistance, including to critical
antimicrobials located on mobile genetic elements (Yang et al., 2018; Yuan et al., 2019; Gou et al.,
2020; Martins et al., 2020; Soliman et al., 2020). The virulence features of E. hormaechei are
insufficiently studied. The genomic plasticity of this species may explain its ability to spread in hospital
environments (Paauw et al., 2009; Roberts et al., 2020).
E. hormaechei has also been associated with respiratory disease in un-weaned calves (Wang et al.,
2020).
Multiresistant E. hormaechei has been isolated from several food products. Examples are a shrimp
sample from a farmers’ market in the US harbouring sul1, sul2, qnrA1, oqxAB, dfrA23, blaACT, floR,
fosA, tet(A), aph(6)-Id and aph(30)-Ib antibiotic resistance genes and several plasmids (Indugu et al.,
2020); an isolate from a raw beef patty with blaVIM-1, mcr-9 aac(60)-Il, ΔaadA22, aac(60)-Ib-cr, sul1,
dfrA1 on a plasmid (Sadek et al., 2020).
Conclusion on a recommendation for the QPS status
Enterobacter hormaechei cannot be recommended for the QPS status due to its pathogenic
potential for humans and animals.
Lactococcus garvieae
Identity
L. garvieae is a bacterial species name with standing in nomenclature (Collins et al., 1983; Schleifer
et al., 1985).
Body of knowledge
This bacterial species has been isolated from a variety of terrestrial and aquatic environments.
L. garvieae has been found in raw milk and sporadically in the bacterial communities of fermented
dairy products. In a single study, L. garvieae has been used as a cheese starter culture (Guarcello
et al., 2016).
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Safety concerns
The pathogenicity of L. garvieae has been reviewed by Gibello et al. (2016). This species is a
recognised fish pathogen responsible for high mortality haemorrhagic septicaemia in wild fish and in
fish farmed in fresh and sea water (Shahi and Mallik, 2020). It has also been associated with bovine
mastitis (Sorge et al., 2021). L. garvieae is also a rare human pathogen of increasing clinical
significance, facilitated by predisposing factors, being responsible for infections such as endocarditis,
urinary tract infections and septicaemia (Gibello et al., 2016; Choksi and Dadani, 2017; Lee et al.,
2020).
Conclusions on a recommendation for the QPS status





The genus Eremothecium contains five species of ascomycetous yeasts or yeast-like fungi and
belongs to the family Saccharomycetaceae (Prillinger et al., 1997; Kurtzman et al., 2011). The species
E. ashbyi was first described in 1935 and it is a legitimate species and name (Mycobank, Index
Fungorum). A synonym name is Crebrothecium ashbyi, which however has been little used. The
species designation has repeatedly been spelled ashbyii; however, this is considered by Kurtzman et al.
(2011) as an orthographic error.
Body of knowledge
A special feature of E. ashbyi (and other species of the genus) is growth predominantly as pseudo-
hyphae and absence of budding. The ascospores in this genus are sickle- or needle-shaped.
Very little information is available on the ecology of E. ashbyi. It has been isolated mostly in
cropping systems of tropical or subtropical regions, e.g. cotton and citrus fruit. Batra (1973)
considered it to be a relatively rare fungus. No other information was found on the possible occurrence
of the species in the food and feed chains.
Along with other species of the genus, E. ashbyi has been widely used in biotechnology since the
1950s for production of useful compounds. The main interest has been the overproduction of
riboflavins by some strains (Kapralek, 1962; Semenova et al., 2017). Additionally, some studies report
extraction of accumulated lipids and essential oils from the biomass of E. ashbyi (He et al., 2019;
Vijayalakshmi et al., 2003).
Safety concerns
There are no reports indicating that E. ashbyi might be pathogenic to humans or any other animals.
However, some studies characterise it as a plant pathogen, since it has been shown to be able to
cause stigmatomycosis (or ‘yeast spot’) in citrus fruit (Batra, 1973), soybean (Kimura et al., 2008a)
and azuki bean (Kimura et al., 2009). A likely route of transmission to new places of infection is via
stink bugs that have fed on infected plants or plant material (Kimura et al., 2008b).
Conclusions on a recommendation for the QPS status
E. ashbyi is not recommended for the QPS list due to its plant pathogenicity and lack of body of
knowledge on its occurrence in the food and feed chains.
Monitoring of new safety concerns related to organisms on the QPS list
The summaries of the evaluation of the possible safety concerns for humans, animals or the
environment described and published since the previous ELS exercise (i.e. articles published between
July 2020 and December 2020 as described in Appendices B and C with reference to the articles
selected as potentially relevant for the QPS exercise (Appendix D) for each of the TUs or groups of
TUs that are part of the QPS list (Appendix E), are presented below.
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3.3. Gram-positive non-sporulating bacteria
3.3.1. Bifidobacterium spp.
A search for papers potentially relevant for QPS-listed Bifidobacterium spp. provided 315
references. The artificial intelligence (AI) analysis left 150. Title screening left 14 references for
abstract inspection, then 8 for a full article appraisal. This last step identified two articles (Pillai et al.,
2020; Takiguchi et al., 2021) dealing with safety concerns. The first article (Pillai et al., 2020)
described a case of bacteraemia in a premature baby girl who was given a probiotic mixture
containing, amongst other organisms, Bifidobacterium longum. The isolated strain from blood culture
was compared to the one from the probiotic and was indistinguishable, but the methods of isolation
and genotyping were not provided. The authors concluded that the infection was a likely adverse
event of the probiotic supplementation. In the second article (Takiguchi et al., 2021), the authors
described a case of an old woman hospitalised with an infection in the peribronchial connective tissue
caused by Bifidobacterium longum and Veillonella species, cultured from a transbronchial needle
aspirate. However, the role of B. longum in the infection was not elucidated since it was identified
together with Veillonella species.
Based on the available evidence, the QPS status of the QPS-listed Bifidobacterium spp. is not
changed.
Carnobacterium divergens
A search for potentially relevant papers on C. divergens provided eight references. No article was
considered relevant at the level of title screening for this TU. Consequently, the QPS status of
C. divergens is not changed.
Corynebacterium glutamicum
A search for papers potentially relevant to the QPS evaluation of C. glutamicum provided 34
references. One paper reached the level of title and abstract screening but did not reach full text
evaluation. Therefore, no new safety concerns were identified and the QPS status of C. glutamicum is
not changed.
Lactobacilli
Analysis of papers referring to any of the QPS species, formerly belonging to the genus
Lactobacillus and recently split into 13 new genera, provided 853 references. The AI analysis left 423
articles. Title screening of these provided 14 references for abstract inspection, which further reduced
their number to 5. However, full paper review excluded all of them, either because no reliable
microorganism identification procedures were described or due to uncertainty on the aetiology of the
cases described.
Based on the available evidence as described above, the QPS status of any of the QPS species
included in the genus Lactobacillus is not changed.
Lactococcus lactis
A search for papers potentially relevant for the QPS status of L. lactis provided 275 references. The
AI analysis left 126 papers. Title and abstract screenings of these reduced their number to 11. Two
papers reached full article evaluation but neither of them dealt with a possible safety concern
pertaining to L. lactis.
Based on the available evidence as described above, the QPS status of L. lactis is not changed.
Leuconostoc spp.
A search for papers potentially relevant for the QPS evaluation of Leuconostoc species provided 95
references. The analysis of their titles left 10 articles for title/abstract screening. Six articles, of which
one was not in English, reached full text evaluation, and five dealt with possible safety concerns.
These were excluded because either the isolation procedure or the identification procedures were
considered unreliable. Consequently, the status of QPS-listed Leuconostoc spp. is not changed.
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Microbacterium imperiale
A search for papers potentially relevant for the QPS evaluation of Microbacterium imperiale
provided one reference. The analysis of the title led to this reference being discarded. Consequently,
the QPS status of M. imperiale is not changed.
Oenococcus oeni
A search for papers potentially relevant for the QPS evaluation of Oenococcus oeni provided 36
references. The analysis of their titles left two articles for title/abstract screening. One article reached
full text evaluation but did not raise any safety concerns. Consequently, the QPS status of O. oeni is
not changed.
Pediococcus spp.
A search for papers potentially relevant for the QPS evaluation of Pediococcus spp. provided 193
references. The analysis of their titles left four articles for the title/abstract phase. Two articles reached
the full text evaluation stage but neither of them identified a safety concern. Consequently, the status
of QPS-listed Pediococcus spp. is not changed.
Propionibacterium spp.
A search for papers potentially relevant for the QPS evaluation of Propionibacterium spp. provided
36 references. Following the analysis of their titles, no articles were selected for abstract screening or
the full article evaluation phase; thus, no new safety concerns were identified. Consequently, the
status of QPS-listed Propionibacterium spp. is not changed.
Streptococcus thermophilus
A search for papers potentially relevant for the QPS evaluation of Streptococcus thermophilus
provided 79 references. The analysis of their titles left one article for title and abstract screening that
did not deal with safety concerns. Therefore, no article reached the evaluation phase, and the QPS
status of S. thermophilus is not changed.
3.3.2. Gram-positive spore-forming bacteria
Bacillus spp.
A search for papers potentially relevant for Bacillus spp. provided 1,123 references. The AI analysis
left 557 articles. The analysis of their titles by two experts left 13 articles for the abstract phase and,
from these, four articles passed to the full text phase for further analysis. Two papers did not deal with
safety concerns. Two papers were further analysed. Song et al. (2020) described Bacillus licheniformis
as possibly involved in bovine mastitis. The paper had methodological flaws in relation to strain
identification and did not document source attribution. Princess et al. (2020) described the isolation of
B. clausii from the blood of a patient, who had been treated with a B. clausii probiotic. The
identification via the blood isolate was performed by MALDI-TOF and the link to the probiotic strain
was not confirmed. The authors reported the patient as immunocompetent, but the patient had
underlying diseases, being a type II diabetic who had undergone several surgical procedures and was
being treated for a tracheal infection while taking the probiotic.
The ELS did not identify any information that would change the status of members of Bacillus spp.
included in the QPS list.
Geobacillus stearothermophilus
A search for papers potentially relevant for G. stearothermophilus provided 1,123 references. The
AI analysis left 557 articles. The analysis of their titles by two experts left 13 articles and for four of
these the full text was analysed. None dealt with this species. Consequently, the QPS status G.
stearothermophilus is not changed.
Pasteuria nishizawae
A search for papers potentially relevant for the QPS evaluation of P. nishizawae provided one
reference, which was excluded during title screening. Consequently, the QPS status of P. nishizawae is
not changed.
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3.3.3. Gram-negative bacteria
Gluconobacter oxydans
A search for papers potentially relevant to the QPS evaluation of G. oxidans and Xanthomonas
campestris provided 200 references.
The analysis of their titles left two articles, but these were excluded following the title and abstract
screening; therefore, no paper reached the final selection phase for this TU. Consequently, the QPS
status of G. oxydans is not changed.
Xanthomonas campestris
The search for papers potentially relevant for the QPS evaluation of Gluconobacter oxidans and X.
campestris provided 200 references. The analysis of their titles left two articles, which reached the
evaluation phase for this TU, but neither eventually dealt with health nor safety concerns.
Consequently, the QPS status of X. campestris is not changed.
3.3.4. Yeasts
The ELS searches for potentially relevant studies on the yeasts with QPS status provided 1,349
references. The AI analysis left 673 articles. After title screening by two experts, 74 studies remained
for the title/abstract phase, and from these 36 articles passed to the full article appraisal. Out of these,
21 reported a possible safety concern.
Two studies were considered relevant for the QPS evaluation but did not directly report safety
concerns. Boontham et al. (2020) proposed a name change of the QPS species Candida cylindracea to
Limtongozyma cylindracea. Libkind et al. (2020) discussed the use of full genome sequencing for
taxonomic identification of yeasts.
Twenty-one studies discussed potentially relevant safety concerns for QPS yeast species, which are
discussed below.
For the species Candida cylindracea, Kluyveromyces lactis, Komagataella pastoris,
Komagataella phaffi, Ogataea angusta, Saccharomyces bayanus, Saccharomyces
pastorianus, Schizosaccharomyces pombe, Xanthophyllomyces dendrorhous and
Zygosaccharomyces rouxii, no safety concerns were newly reported. Consequently, the QPS status
does not change for these species.
Cyberlindnera jadinii
The anamorph name of C. jadinii is Candida utilis.
In a retrospective study for 1999–2018, Kaur et al. (2020) identified 7927 yeast isolates (out of
602,963 isolates in total) from patients with suspected sepsis in intensive care units in a hospital in
India. They reported that C. jadinii represented 2.8% of the yeasts and 0.03% of total isolates
(identification by conventional methods and MALDI-TOF MS, but no confirmation with DNA-based
molecular methods). Yamin et al. (2020) found in a retrospective study (2001–2018) on isolates from
patients with candidaemia in a hospital in Malaysia, that a very low incidence (one isolate or 0.1%)
was C. jadinii. In a retrospective study of isolates from patients with fungaemia in 12 hospitals in Italy
(Prigitano et al., 2020), one of the isolates (0.3%) was C. jadinii (identification by conventional
methods and MALDI-TOF MS). The incidence was very low and identification by MALDI-TOF was not
further confirmed by a DNA-based molecular methodology.
The inconsistency of the identification, together with the scarcity of linkage of this organism to
pathology, resulted in the decision that the QPS status of C. jadinii is not changed.
Hanseniaspora uvarum
The anamorph name of H. uvarum is Kloeckera apiculata.
Zalewski et al. (2020) investigated the causes of cranberry fruit rot (CFR) in a cranberry farm in
Wisconsin, USA. They show that in rare cases (CFR is usually caused by filamentous fungi), H. uvarum
can cause CFR and thus cause spoilage of harvested cranberries.
This new report did not add any new information that would change the current QPS status of this
species.
Kluyveromyces marxianus
The anamorph name of K. marxianus is Candida kefyr.
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Seth-Smith et al. (2020) reported bloodstream infection with K. marxianus in a 61-year-old male.
He was immunocompromised due to acute myeloid leukaemia and chemotherapy and prophylaxic
antibiotic treatment, and species identification (growth on chromogenic media and MALDI-TOF MS) did
not apply DNA-based molecular methods. A study in a hospital in India (Sankari et al., 2020) reported
that 2% of yeasts recovered from the saliva of patients with oral squamous cell carcinoma were
K. marxianus. The patients, however, had not been diagnosed with fungal infection. Yamin et al.
(2020) found in a retrospective study (2001–2018) on isolates from patients with candidaemia in a
hospital in Malaysia, that one of the isolates (incidence only 0.1%) was K. marxianus. In a
retrospective study of isolates from patients with fungaemia in 12 hospitals in Italy (Prigitano et al.,
2020), one of the isolates (low incidence of 0.3%) was K. marxianus (identification by conventional
methods and MALDI-TOF MS). Eghtedar Nejad et al. (2020) identified yeast isolates from HIV patients
in a hospital in Iran and a non-HIV control group. One isolate in each group (corresponding to only
1% of isolates) was K. marxianus. A study of isolates from women in Iran diagnosed with vulvovaginal
infection (Farahyar et al., 2020) showed that K. marxianus may in rare cases (prevalence 1.6%) cause
vulvovaginal infections. The results of two additional studies reporting a low prevalence (< 2%) of
K. marxianus in vulvovaginal infections (Ignjatovic et al., 2020) and nosocomial fungal infections in
patients that had undergone abdominal surgery (Kilic et al., 2020) could not be appropriately
evaluated since there were uncertainties in the species identification.
In conclusion, the literature update mentioned mainly the isolation of K. marxianus from patients
who are immunocompromised and/or have underlying disease and there is a scarcity of linkage of this
organism to pathology. The prevalence of K. marxianus in the retrospective studies was very low. Also,
methodological problems concerning identification (no confirmation by use of DNA-based molecular
methods) and source attribution were noted. Thus, the papers did not identify any information that
would change the QPS status of K. marxianus.
Yarrowia lipolytica
The anamorph name of Y. lipolytica is Candida lipolytica.
Chi et al. (2021) report a case where a 44-year-old man in Taiwan treated for gastric
adenocarcinoma by gastric surgery and chemotherapy developed fungaemia caused by Y. lipolytica.
Predisposing conditions were a central venous catheter and an infection with Acinetobacter baumannii.
Yamin et al. (2020) found in a retrospective study (2001–2018) on isolates from patients with
candidaemia in a hospital in Malaysia, that four of the isolates (incidence only 0.3%) were Y. lipolytica.
In a retrospective taxonomic study on 85 ‘uncommon Candida species’ isolates from patients with
candidaemia in hospitals in Taiwan (Huang et al., 2020), three isolates were identified as Y. lipolytica
by conventional methods, MALDI-TOF MS and DNA sequencing. However, no information was given on
pathology or any predisposing factors for infection. Huang et al. (2020) also showed that conventional
methods often led to misidentification, especially of Candida sake and the QPS species D. hansenii.
The literature update did not identify any information that would change the current QPS status of
Y. lipolytica.
Debaryomyces hansenii
The anamorph name of D. hansenii is Candida famata.
Six references related to possible concerns for human safety were identified. Sankari et al. (2020)
reported the prevalence of Candida species in the saliva of patients with oral squamous cell carcinoma,
other oral potentially malignant disorders and healthy cohorts in a hospital in India and 17% were
identified as C. famata. Yamin et al. (2020) found in a retrospective study (2001–2018) on isolates
from patients with candidaemia in a hospital in Malaysia, that 1.7% of the isolates were C. famata
from patients with oral squamous cell carcinoma. All these patients had disorders that could
predispose them to infection. In a retrospective taxonomic study on 85 ‘uncommon Candida species’
isolates from patients with candidaemia in hospitals in Taiwan (Huang et al., 2020), four isolates were
identified as C. famata by conventional methods, MALDI-TOF MS and DNA sequencing. Huang et al.
(2020) also showed that conventional methods often led to misidentification, especially of Candida
sake and the QPS species D. hansenii. In this study, no information was given on pathology or any
predisposing factors for infection. Vasileiou et al. (2020) report the cases of candidaemia in paediatric
patients with malignancies in hospitals in Greece, and 15.8% of the isolates were described as
C. famata. Almasadi et al. (2020) report five isolates of C. famata from a total of 79 microbial isolates
from patients with nosocomial, opportunistic infections in a paediatric intensive care unit at a hospital in
Saudi Arabia. The report of Mello et al. (2021) also has problems with the identification methodology
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used; the yeast isolates were identified only by using conventional growth-based tests and not confirmed
by molecular approaches. This study indicates that C famata might contribute to dermatomycosis or
onychomycosis in humans. In these three reports, species identification is unclear. The retrospective
studies did not provide further information on the cases reported.
The reports on D. hansenii did not add any new information that would change the current QPS
status of this species.
Saccharomyces cerevisiae
The anamorph form of S. cerevisiae is not described. A synonym of this species is Saccharomyces
boulardii.
Four references reported safety concerns for humans and, in all of them, the identification is
uncertain. Ventoulis et al. (2020) report that two cases of critically ill patients who had to be hospitalised
in an ICU due to Sars-CoV-2 infection received S. cerevisiae supplementation because of diarrhoea and
subsequently developed a S. cerevisiae bloodstream infection. The identification was done using a
morphological approach and API ID 32C. In a retrospective study of isolates from patients with
fungaemia in 12 hospitals in Italy (Prigitano et al., 2020), three of the isolates (0.3%) were S. cerevisiae
(identification by conventional methods and MALDI-TOF MS). Ignjatovic et al. (2020) describe six cases
(2%) of vulvovaginal infection caused by S. cerevisiae from a hospital in Serbia using only traditional
growth-based methods for the species identification. Finally, Noni et al. (2020) describe a 12-year
retrospective study of fungal infections at a children’s’ hospital in Greece. All patients had a serious
underlying disease and had acquired an opportunistic fungal infection. Six of 416 subjects (1.4%) had
S. cerevisiae infection. It is not possible to know which specific method(s) was used to identify
S. cerevisiae. The retrospective studies did not provide further information on the cases reported.
The reports on S. cerevisiae did not add any new information that would change the current QPS
status of this species.
Wickerhamomyces anomalus
The anamorph name of W. anomalus is Candida pelliculosa.
Kaur et al. (2020), in a retrospective study, from a total of 602,963 blood samples from patients
with suspected sepsis, identified in intensive care units in a hospital in India, that W. anomalus
constituted 13.1% of yeast isolates (identification by conventional methods and MALDI-TOF MS). In a
retrospective taxonomic study on 85 ‘uncommon Candida species’ isolated from patients with
candidaemia in hospitals in Taiwan (Huang et al., 2020), 15 isolates were identified as W. anomalus by
conventional methods and MALDI-TOF MS. Pandey et al. (2020) report the identification of 119 yeast
isolates from patients diagnosed with blood-stream candidiasis in an intensive care unit of a hospital in
India. Using MALDI-TOF MS, 15 isolates were identified as W. anomalus. In these three reports,
species identification is uncertain because of the low resolution of the methods used for yeast
identification. Sankari et al. (2020) reported the prevalence of Candida species in the saliva of patients
with oral squamous cell carcinoma, oral potentially malignant disorders and healthy cohorts in a
hospital in India, and 33% were identified as C. pelliculosa in patients with oral squamous cell
carcinoma. Yamin et al. (2020) found in a retrospective study (2001–2018) on isolates from patients
with candidaemia in a hospital in Malaysia, that four of 1,175 isolates (0.3%) C. pelliculosa. The
retrospective studies did not provide further information on the cases reported.
Finally, Dutra et al. (2020) report a case of infection by W. anomalus in a 19-month-old Brazilian
female who had a previous history of prematurity, cardiac surgery due to patent ductus arteriosus and
a long period of hospital stay.
The reports assessed in this period showed inconsistency in the identification, predisposing factors
for human infection and/or a lack of information on the cases reported.
The literature update did not identify any information that would change the current QPS status of
W. anomalus.
3.3.5. Protists/Algae
ELS was performed for all three species together, as indicated below.
A search for papers potentially relevant for the QPS evaluation of protists/algae provided 84
references. The analysis of their titles left 42 articles for title/abstract screening. Eight articles reached
full text evaluation. Four of eight articles dealt with potential safety concerns of which two were on
A. limacinum, one on Schizochytrium limacinum and one on T. chuii (see below).
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Aurantiochytrium limacinum
A. limacinum is a member of the Thraustochytriacea and is a protist. The taxonomic classification of
the genus Schizochytrium has been subject to discussion in 2007 (Yokoyama and Honda, 2007). Based
on genetic and phenotypic analysis, the authors proposed changes in the classification. The genus
Schizochytrium was amended and new genera such as Aurantiochytrium and Oblongichytrium were
defined. The species Schizochytrium llmacinum can also be referred to as Aurantiochytrium limacinum.
No article indicated a safety concern; therefore, the current QPS status of A. limacinum is not
changed.
Euglena gracilis
No article dealt with potential safety concerns of E. gracilis. Therefore, the current QPS status of E.
gracilis is not changed.
Tetraselmis chuii
One article on T. chuii dealt with a potential safety concern, however, this concern was not
confirmed after full text evaluation. Therefore, the current QPS status of T. chuii is not changed.
3.3.6. Viruses used for plant protection
Alphaflexiviridae and Potyviridae
A search for papers potentially relevant for the QPS evaluation of viruses of the Alphaflexiviridae
and Potyviridae provided 31 references. After title screening, no paper reached the title/abstract
screening stage; thus, no new safety concern was identified. Therefore, the current QPS status
remains unchanged.
Baculoviridae
A search for papers potentially relevant for the QPS evaluation of Baculoviridae provided 43
references. One article dealing with Baculoviridae passed the title screening but did not reach the full
article evaluation stage, thus no new safety concern was identified. Therefore, the current QPS status
remains unchanged.
Conclusions
ToR 1: Keep updated the list of biological agents being notified, in the context of a
technical dossier to EFSA Units (such as Feed, Food Ingredients and Packaging, Nutrition,
Pesticides, Genetically Modified Microorganisms), for intentional use in feed and/or food
or as sources of food and feed additives, enzymes, plant protection products for safety
assessment:
• Between October 2020 and March 2021, the list of notifications was updated with 78
notifications that were received by EFSA, of which 55 were proposed for evaluation as feed
additives, 13 for use as food enzymes, food additives and flavourings, 8 as novel foods and 2
as plant protection products.
ToR 2: Review taxonomic units previously recommended for the QPS list and their
qualifications when new information has become available:
In relation to the results of the monitoring of possible new safety concerns relevant for the QPS list,
there were no results that would justify removal of any TUs from the QPS list. Schizochytrium
limacinum, which is a synonym for Aurantiochytrium limacinum, is added to the QPS list.
ToR 3: (Re)assess the suitability of taxonomic units notified to EFSA not present in the
current QPS list for their inclusion in that list:
• Out of the 78 notifications received, 44 were related to TUs that already had QPS status and
did not require further evaluation.
• Of the remaining 34 notifications, 27 were related to TUs excluded from QPS evaluation: 16
were notifications of filamentous fungi, 1 of Enterococcus faecium, 7 of Escherichia coli, 1 of
Streptomyces spp. and 2 notifications (Dyella spp. and Schizochytrium sp. strain CABIO-A-2)
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were only a genus, or a specific strain, and not a species and were therefore not eligible for
QPS evaluation.
• Seven notifications, corresponding to 7 TUs, were evaluated for possible QPS status.
Corynebacterium stationis and Kodamaea ohmeri were re-assessed because an update was
requested in relation to the current mandate. Five TUs (Anoxybacillus caldiproteolyticus,
Bacillus paralicheniformis, Enterobacter hormaechei, Eremothecium ashbyi and Lactococcus
garvieae) were assessed for the first time.
• Corynebacterium stationis is not recommended for QPS status due to a lack of body of
knowledge in relation to its occurrence in the food and feed chain and to possible safety
concerns in relation to human health.
• Kodamaea ohmeri is not recommended for QPS status due to safety concerns in relation to
human health.
• Anoxybacillus caldiproteolyticus is not recommended for QPS status due to a lack of body of
knowledge on its occurrence in the food and feed chain.
• Bacillus paralicheniformis is recommended for the QPS status with the qualifications ‘absence
of toxigenic activity’ and ‘absence of genetic information to synthesize bacitracin’.
• Enterobacter hormaechei is not recommended for QPS status due to its pathogenic potential
for humans and animals.
• Eremothecium ashbyi is not recommended for QPS status due to a lack of body of knowledge
on its occurrence in the food and feed chain and its plant pathogenicity.
• Lactococcus garvieae is not recommended for QPS status due to its pathogenic potential for
humans and animals.
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Glossary
Anamorph name Valid name of a fungus based on the asexual reproductive state
(morphologically).
Antimicrobial compounds Antibiotics, bacteriocins and/or small peptides with antimicrobial
activity.
Basonym name the earliest validly published name of a taxon.
Synonymous name/Homotypic
synonym
have the same type (specimen) and the same taxonomic rank.





BIOHAZ EFSA Panel on Biological Hazards
BMECs bovine mammary epithelial cells
CFR cranberry fruit rot
ELS extensive literature search
FEEDAP EFSA Panel on Additives and Products or Substances used in Animal Feed
FIP EFSA Food ingredients and Packaging Unit
FSTA Food Science Technology Abstracts
GMM genetically modified microorganism
GMO EFSA Unit on Genetically Modified Organisms
MALDI-TOF matrix-assisted laser desorption/ionization (MALDI), time-of-flight (TOF)
QPS qualified presumption of safety
PPR Pesticide Peer Review Unit
ToR Term(s) of reference
TU taxonomic unit
WG working group
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Appendix A – Search strategy followed for the (re)assessment of the
suitability of TUs notified to EFSA not present in the current QPS list for
their inclusion in the updated list (reply to ToR 3)
A.1. Enterobacter hormaechei
The search on PubMed led to 168 hits with the keyword ‘hormoachei’ 168 hits. All hits were
screened for their relevance.
A.2. Corynebacterium stationis
The search on Scopus led to 17 hits related to Corynebacterium stationis. Among them, seven were
considered appropriate for the assessment.
A.3. Lactococcus garvieae
A search for the body of knowledge on L. garvieae was done in the databases mentioned above,
considering all years available in these databases, using a range of search terms in relation to food
and feed, combined with L. garvieae.
lactococcus AND garvieae AND (infect* OR disease* OR pathog* OR mastit*): 277 hits,
lactococcus AND garvieae AND cheese: 23 hits
lactococcus AND garviae AND (food OR feed OR ferment*): 13 hits
lactococcus AND garvieae AND fish: 213 hits
lactococcus AND garvieae AND mastit*: 18 hits
A.4. Eremothetium ashbyi
Searches were made on Web of Science core collection. ‘(Eremothecium ashbyi) or (E. ashbyi) or
(Eremothecium ashbyii) or (E. ashbyii)’ gave 150 hits, which were all scanned on title level. A similar
search was also done with the synonym Crebrothecium ashbyi, resulting in no additional hits.
A.5. Bacillus paralicheniformis
A search was made on PubMed with the key word ‘Bacillus paralicheniformis’. All 43 hits were
screened.
A.6. Anoxybacillus caldiproteolyticus
Search in Pub-Med for the terms “caldiproteolyticus” and “caldoproteolyticus” provided eight hits.
Five of them were on taxonomy/properties of the organism, while the other three were on description
of related, new Anoxybacillus species.
A.7. Kodamaea ohmeri
Search in Pub-Med for the terms “Kodamaea” and “ohmeri” for the years 2019, 2020 and 2021
resulted in 15 papers, 7 papers and 1 paper, respectively. Collectively, out of these 23 papers one is a
review, two are previous QPS statements, three are related to bioremediation/biochemistry, seven are
related to plant pathology/ecology and 10 are related to (treatment of) opportunistic K. ohmeri
infections in mostly immunocompromised human individuals. Other databases, including Web of
Science core collection, searched for the same terms gave less papers, but with full overlap with the
Pub-Med collection of papers.
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Appendix B – Protocol for Extensive literature search (ELS), relevance
screening and article evaluation for the maintenance and update of list of
QPS-recommended biological agents (reply to ToR 2)
The protocol for extensive literature search (ELS) used in the context of the EFSA mandate on the
list of QPS-recommended biological agents intentionally added to the food or feed (EFSA-Q-2020-
00079) is available on the EFSA Knowledge Junction community on Zenodo, at: https://doi.org/
10.5281/zenodo.5016562
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Appendix C – Search strategies for the maintenance and update of list of
QPS-recommended biological agents (reply to ToR 2)
The search strategies for each taxonomic unit (TU), i.e. the string for each TU and the search
outcome, are available on the EFSA Knowledge Junction community on Zenodo at: https://doi.org/
10.5281/zenodo.5016711
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Appendix D – References selected from the ELS exercise with potential
safety concerns for searches July–December 2020 (reply to ToR 2)
Gram-Positive Non-Sporulating Bacteria
Bifidobacterium spp.
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relevant outcomes? A case report and updated review of literature. Clinical Nutrition ESPEN, 39, 255–259.
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Tan C, Howard JL and Bondy L, 2020. Prosthetic joint infection after total hip arthroplasty caused by Lactobacillus




Bog ES, Erturk O and Yaman M, 2020. Pathogenicity of aerobic bacteria isolated from honeybees (Apis mellifera)
in Ordu Province. Turkish Journal of Veterinary and Animal Sciences, 44, 714–719.
Chen X, Daliri EB-M, Chelliah R and Oh D-H, 2020. Isolation and Identification of Potentially Pathogenic
Microorganisms Associated with Dental Caries in Human Teeth Biofilms. Microorganisms, 8.
Hosoya S, Kutsuna S, Shiojiri D, Tamura S, Isaka E, Wakimoto Y, Nomoto H and Ohmagari N, 2020. Leuconostoc
lactis and Staphylococcus nepalensis Bacteremia, Japan. Emerging Infectious Diseases, 26, 2283–2285.
Omori R, Fujiwara S, Ishiyama H, Kuroda H and Kohara N, 2020. Leuconostoc lactis- A Rare Cause of Bacterial











BIOHAZ statement on QPS: suitability of taxonomic units notified until March 2021
www.efsa.europa.eu/efsajournal 31 EFSA Journal 2021;19(7):6689
Gram-Positive Spore-forming Bacteria
Bacilli
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000097
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Appendix E – Updated list of QPS Status recommended biological agents in
support of EFSA risk assessments
The list of QPS status recommended biological agents (EFSA BIOHAZ Panel, 2020a) is being
maintained in accordance with the mandate of the BIOHAZ Panel (2020–2022), extended for the
following years. Possible additions to this list are included approximately every 6 months, with the last
Panel Statement (13) adopted in December 2020 (EFSA BIOHAZ Panel, 2021). These additions are
published as updates to the Scientific Opinion (EFSA BIOHAZ Panel, 2020a); the updated QPS list is
available at https://doi.org//10.2903/j.efsa.2021.6689 and, as of January 2018, also as supporting
information linked to every Panel Statement available on the Knowledge Junction at https://doi.org/
10.5281/zenodo.4428353.
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Novel foods Novel Food Production of docosahexaenoic
acid (DHA)-rich oil as novel food
EFSA-Q-2020-00850 Y No
Schizochytrium sp. CABIO-A-2 Novel foods Novel Food Production of docosahexaenoic
acid (DHA; 4Z,7Z,10Z,13Z,
16Z,19Z)-docosa-4,7,10,13,16,19-




















































DSM 5749 Feed additives Zootechnical
additives
Zootechnical additive EFSA-Q-2019-00736 N Yes
Bacillus subtilis KCCM-10445 Feed additives Nutritional
additives
Production of Vitamin B2 EFSA-Q-2020-00838 Y No












Nutritional additives: c) amino
acids, their salts and analogues
EFSA-Q-2020-00708 Y No
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KCCM 80245 Feed additives Nutritional
additives






KCCM 80235 Feed additives Sensory
additives




















NBIMCC 8270 Feed additives Nutritional
additives
Gut flora stabiliser in pets and
other non-food-producing animals
EFSA-Q-2020-00690 N No
Escherichia coli BL21 (DE3) Novel foods Novel Food Lacto-N-tetraose production by
fermentation
EFSA-Q-2020-00630 N No
Escherichia coli NITE SD 00329 Feed additives Nutritional
additives

















Escherichia coli K-12 Novel foods Novel Food Production of 20-Fucosyllactose EFSA-Q-2021-00088 N No
Escherichia coli K-12 DH1 Novel foods Novel Food Production of 20-Fucosyllactose/
Difucosyllactose mixture
EFSA-Q-2021-00091 N No
Escherichia coli KCCM 80246 Feed additives Nutritional
additives












E-98 NCIMB 30236 Feed additives Technological
additives
Silage Additive EFSA-Q-2021-00076 N No
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NBIMCC 8242 Feed additives Nutritional
additives





D2/CSL (CECT 4529) Feed additives Zootechnical
additives
Gut flora stabiliser EFSA-Q-2020-00847 Y No
Lactobacillus brevis DSM 12835 Feed additives Technological
additives
Silage Additive EFSA-Q-2020-00691 Y No
Lactobacillus
buchneri
DSM 16774 Feed additives Technological
additives
Silage Additive EFSA-Q-2020-00654 Y No
Lactobacillus
buchneri
DSM 12856 Feed additives Technological
additives
Silage additive EFSA-Q-2020-00769 Y No
Lactobacillus
buchneri
DSM 12856 Feed additives Technological
additives
Silage additive Not yet registered Y No
Lactobacillus
buchneri
DSM 12856 Feed additives Technological
additives




NBIMCC 8244 Feed additives Nutritional
additives






NBIMCC 8250 Feed additives Nutritional
additives





NBIMCC 8269 Feed additives Nutritional
additives





DSM 16245 Feed additives Technological
additives
Silage additive EFSA-Q-2020-00707 Y No
Lactobacillus
plantarum
DSM 8862 Feed additives Technological
additives
Silage Additive EFSA-Q-2021-00131 Y No
Lactobacillus
plantarum
DSM 8866 Feed additives Technological
additives
Silage Additive EFSA-Q-2021-00131 Y No
Lactobacillus
plantarum
IMI 507026 Feed additives Technological
additives
Silage Additive EFSA-Q-2020-00695 Y No
Lactobacillus
plantarum
IMI 507027 Feed additives Technological
additives
Silage Additive EFSA-Q-2020-00696 Y No
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IMI 507028 Feed additives Technological
additives
Silage Additive EFSA-Q-2020-00697 Y No
Lactobacillus
rhamnosus
NCIMB 30121 Feed additives Technological
additives
Silage Additive EFSA-Q-2020-00706 Y No
Lactobacillus
rhamnosus
IMI 507023 Feed additives Technological
additives
Silage Additive EFSA-Q-2020-00692 Y No
Lactococcus
garvieae
20-92 Novel foods Novel Food Lactococcus 20-92 is used to
produce SE5-OH®, a soy-based
product produced by selective
fermentation of soy germ powder
EFSA-Q-2021-00092 N Yes
Lactococcus lactis DSM 11037 Feed additives Technological
additives
Silage additive EFSA-Q-2020-00846 Y No
Lactococcus lactis NCIMB 30160 Feed additives Technological
additives













DSM 16243 Feed additives Technological
additives
Silage additive EFSA-Q-2020-00814 Y No
Pediococcus
acidilactici
NRRL-B-50595 Feed additives Technological
additives
Acidity regulator/preservative EFSA-Q-2021-00099 Y No
Pediococcus
acidilactici
NRRL-B-50964 Feed additives Technological
additives
Acidity regulator/preservative EFSA-Q-2021-00099 Y No
Pediococcus
pentosaceus
IMI 507024 Feed additives Technological
additives
Silage Additive EFSA-Q-2020-00693 Y No
Pediococcus
pentosaceus
IMI 507025 Feed additives Technological
additives
Silage Additive EFSA-Q-2020-00694 Y No
Pediococcus
pentosaceus
DSM 12834 Feed additives Technological
additives
Silage additive EFSA-Q-2020-00845 Y No
Propionibacterium
freudenreichii
DSM 33189 Feed additives Technological
additives
Silage additive Not yet registered Y No
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DSM 33189 Feed additives Technological
additives
Silage Additive EFSA-Q-2021-00127 Y No
Streptococcus
thermophilus
NBIMCC 8253 Feed additives Nutritional
additives

















CBS 589.94 Feed additives Zootechnical
additives
Production of polygalacturonase.
Zootechnical additive – digestibility
enhancer.
EFSA-Q-2020-00840 N No







Used for the production of the
enzyme mannanase
EFSA-Q-2021-00123 N No





Used for the production of the
enzyme beta-galactosidase
EFSA-Q-2020-00710 N No





Used for the production of the
enzyme pectin esterase
EFSA-Q-2021-00072 N No




















HC LU19287 Feed additives Zootechnical
additives
Digestibility enhancer EFSA-Q-2021-00075 N No
Trichoderma
citrinoviride
Bisset IM SD 142 Feed additives Zootechnical
additives












BIOHAZ statement on QPS: suitability of taxonomic units notified until March 2021






















MUCL 49754 Feed additives Zootechnical
additives





MUCL 49755 Feed additives Zootechnical
additives








Digestibility enhancer EFSA-Q-2020-00767 N No
Trichoderma reesei MUCL 49754 Feed additives Zootechnical
additives
Production of endo-1,3(4)-b-
glucanase. Zootechnical additive –
digestibility enhancer.
EFSA-Q-2020-00840 N No
Trichoderma reesei MUCL 49755 Feed additives Zootechnical
additives
Production of endo-1,4-b-xylanase
Zootechnical additive – digestibility
enhancer.
EFSA-Q-2020-00840 N No







Used for the production of the
enzyme arabinofuranosidase
EFSA-Q-2021-00120 N No













CCTCCM 2019833 Feed additives Nutritional
additives
Vitamin B2 (Riboflavin) for all
animal species
EFSA-Q-2020-00323 N Yes





Used in an improved
manufacturing process to produce




GS1115-KI Feed additives Zootechnical
additives
Digestibility enhancer EFSA-Q-2021-00098 Y No
Komagataella
phaffii
DSM 23036 Feed additives Zootechnical
additives
Digestibility enhancer EFSA-Q-2021-00152 Y No
Yarrowia lipolytica Novel foods Novel Food Production of biomass as novel
food
EFSA-Q-2020-00655 Y No
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Yarrowia lipolytica GM strain Feed additives Sensory
additives
Production of Canthaxanthin
(sensory additive, colourant and
technological additive)
EFSA-Q-2021-00149 Y No
Yarrowia lipolytica GM strain Feed additives Sensory
additives
Production of Canthaxanthin
(sensory additive, colourant and
technological additive)
EFSA-Q-2021-00150 Y No
(a): To find more details on specific applications please access the EFSA website – openEFSA.
(b): Where no link is given, this means that the risk assessment has not yet been published.
(c): Included in the QPS list as adopted in December 2019 (EFSA BIOHAZ Panel, 2020b) and respective updates which include new additions (latest: EFSA BIOHAZ Panel, 2021).
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